Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.58
Bid: 39.22
Ask: 39.46
Change: -0.02 (-0.05%)
Spread: 0.24 (0.612%)
Open: 39.12
High: 39.58
Low: 39.12
Prev. Close: 39.60
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Oct 2022 07:00

RNS Number : 7831B
Assura PLC
05 October 2022
 

5 October 2022

Assura plc

 

Trading Update

For the first half ending 30 September 2022

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first half of the year to 30 September 2022.

 

Jonathan Murphy, CEO, said:

"Following another period of good progress, Assura continues to be well positioned to meet the UK's strong underlying demand for quality primary care and community health buildings as a partner of choice for the NHS.

"Highly targeted and selective acquisitions and developments during the first half of the year, along with the disposal of 61 properties for £73 million, have further strengthened the quality of our portfolio, which now stands at 603 properties with an annual rent roll of £139 million and a weighted average unexpired lease term of 11.4 years.

"Our financial position remains very strong. Our debt book is fixed at an average interest rate of 2.3% with a long-term average maturity of 7.5 years, and we have cash and committed undrawn facilities totalling £284 million.

"Together with the strength of our portfolio and expertise of our teams, we are well placed to take advantage of the opportunities ahead. That said, we recognise the current macro-economic uncertainty and industry-wide inflationary pressure and will continue to monitor and take a cautious approach to capital investment to ensure long-term success."

 

Strong track record of disciplined investment alongside ongoing capital recycling

· Portfolio currently stands at 603 properties with an annualised rent roll of £139.3 million

· Invested £141 million on additions during the half at an average yield on cost of 5.0%; six development completions, 13 acquisitions and three assets in co-investment arrangements, largely in the first quarter

· Three developments started on site, including our first net zero carbon project in Fareham

· Completed disposal of portfolio of 61 properties for £73 million at a small premium to book value

· Seven lease regears completed (£1.1 million of existing rent)

· Completed five asset enhancement capital projects (total spend £2.2 million); on site with a further six (total spend £8.8 million)

 

Development and acquisition pipelines provide growth opportunities

· Currently on site with 13 developments; total cost of £153 million (March 2022: 17, £166 million) of which £65 million has been spent to date

· Immediate development pipeline of 10 schemes, where we would normally expect to be on site within 12 months; total cost of £83 million (March 2022: 20, £158 million). We continue to experience some delays to construction timetables and start dates

· Monitoring the extended development and acquisition pipelines as well as the immediate development pipeline in light of the current macro-economic environment

· 35 lease re-gears covering £6.4 million of existing rent roll in the current pipeline

· Pipeline of 18 capital asset enhancement projects (projected spend £10.5 million) over the next two years

 

Strong and sustainable financial position

· At 30 September 2022 net debt stood at £1,092 million with cash and undrawn facilities of £284 million

· All drawn facilities are unsecured with fixed interest (weighted average interest rate of 2.3%) and weighted average maturity 7.5 years

 

 

- ENDS -

 

 

 

 

Assura plc Jayne Cottam, CFO David Purcell, Investor Relations Director

Tel: 01925 945354 Email: Investor@assura.co.uk

 

FGS Global

Gordon SimpsonJames Thompson

 

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

 

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at £2,752 million.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

 

Further information is available at www.assuraplc.com

 

Assura plc LEI code: 21380026T19N2Y52XF72

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIDIVLSIIF
Date   Source Headline
30th Jan 20159:42 amRNSNotification of Major Interest in Shares
29th Jan 20153:56 pmRNSNotification of Vesting of Share Award to PDMR
28th Jan 20158:21 amRNSAdmission of Assura plc shares
27th Jan 20151:53 pmRNSCourt hearing approves new corporate structure
23rd Jan 20152:27 pmRNSPublication of Prospectus
23rd Jan 201511:08 amRNSTR-1: Notification of Major Interest in Shares
14th Jan 201512:42 pmRNSResults of Shareholder Meetings
12th Jan 20157:00 amRNSForward funding and acquisition update
7th Jan 20157:00 amRNSAssura completes Sudbury Community Health Centre
17th Dec 20145:27 pmRNSPosting of Shareholder Circular & Meeting Notices
17th Dec 201410:16 amRNSAcquisition of a medical centre for £10.1 million
16th Dec 201412:12 pmRNSNew Corporate Structure
15th Dec 20143:12 pmRNSAcquisition of three medical centres for £11.5m
3rd Dec 20147:00 amRNSAssura completes Kidderminster purchase agreement
2nd Dec 20143:22 pmRNSNotification of Major Interest In Shares
28th Nov 20144:40 pmRNSSecond Price Monitoring Extn
28th Nov 20144:35 pmRNSPrice Monitoring Extension
28th Nov 201410:05 amRNSTotal Voting Rights
27th Nov 20142:26 pmRNSConfirmation of Quarterly Interim Dividend
25th Nov 20147:00 amRNSInterim Results 2014
6th Nov 20147:00 amRNS£63m acquisition and £21m development agreement
3rd Nov 20143:47 pmRNSNotification of Major Interest in Shares
3rd Nov 201412:20 pmRNSNotification of Major Interest in Shares
3rd Nov 20147:00 amRNSAssura adds four new medical centres
22nd Oct 20145:42 pmRNSNotification of Major Interest in Shares
22nd Oct 20144:52 pmRNSNotification of Major Interest in Shares
22nd Oct 201410:23 amRNSNotification of Major Interest in Shares
20th Oct 20141:00 pmRNSNotification of Major Interest in Shares
17th Oct 20149:25 amRNSNotification of Major Interest in Shares
16th Oct 20145:37 pmRNSNotification of Major Interest in Shares
16th Oct 20145:32 pmRNSNotification of Major Interest in Shares
16th Oct 20141:29 pmRNSDirector/PDMR Shareholding
16th Oct 20141:29 pmRNSTR-1: Notification of Major Interest in Shares
16th Oct 201412:38 pmRNSNotification of Major Interest in Shares
15th Oct 20142:58 pmRNSConfirmation of Quarterly Interim Dividend
14th Oct 20143:36 pmRNSResult of Extraordinary General Meeting
14th Oct 20143:15 pmRNSNotification of Major Interest in Shares
13th Oct 20144:27 pmRNSTR-1: Notification of Major Interest in Shares
13th Oct 20142:54 pmRNSTR-1: Notification of Major Interest in Shares
10th Oct 20147:00 amRNSResult of Proposed Share Issue
30th Sep 20146:05 pmRNSTR-1: Notification of Major Interest In Shares
24th Sep 20141:56 pmRNSPublication of Prospectus
24th Sep 20147:00 amRNSProposed Share Issue and Notice of EGM
4th Sep 201411:46 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
21st Aug 20147:00 amRNSAcquisition and funding agreement
14th Aug 201411:14 amRNSNotification of Major Interest in Shares
13th Aug 20145:08 pmRNSNotification of Major Interest in Shares
31st Jul 20147:00 amRNSInterim Management Statement
23rd Jul 20147:00 amRNSAcquisition of Medical Centre
22nd Jul 20145:29 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.